Check out the companies that are trending in intraday trading. JPMorgan — Announces that net interest income levels may be lower than Wall Street analysts expected in 2024, despite beating both top and bottom line estimates last quarter After that, the bank fell 5%. CEO Jamie Dimon also highlighted the dangers of inflationary pressures. Wells Fargo — The company’s stock price fell less than 1% after the company reported a decline in net interest income in the first quarter. Wells Fargo’s first-quarter adjusted earnings and sales exceeded analysts’ expectations. BlackRock — BlackRock’s stock price fell nearly 2%. Asset managers reported lower-than-expected total net inflows per street account. BlackRock’s first-quarter adjusted earnings were $9.81 per share on revenue of $4.73 billion, compared with analyst estimates compiled by LSEG for revenue of $4.68 billion. It exceeded $9.35. Globe Life — The life insurance stock rose 10% after plunging more than 50% during Thursday trading. This decline was caused by a report from Fuzzy Panda Research. The company disclosed short positions in the stock and raised allegations of insurance fraud. Paramount — The entertainment company fell nearly 2% after it revealed plans to reduce the number of directors on its board from 11 to seven. Paramount is currently in talks to merge with Skydance Media. Corteva — Pesticide stocks fell 3.8% after JPMorgan downgraded the stock to neutral from overweight. The company said the expected weakness does not make it worth buying the stock ahead of its first-quarter earnings release. SIENA — The stock price fell nearly 3% after Citi initiated coverage of a sell rating on the software company. The bank said investors are too optimistic about potential artificial intelligence tailwinds, but those tailwinds are further away than expected. Zoetis — the pet drug company fell more than his 7%. The decline followed a Wall Street Journal report that investigated potential side effects of Zoetis’ arthritis drugs Librera and Sorrencia. Arista Networks — Shares fell 9% following Rosenblatt’s double downgrade from buy to sell. The company warned that Arista’s artificial intelligence opportunity may be smaller than expected. —CNBC’s Michelle Fox, Alex Harring, Tanaya Machel and Pia Singh contributed reporting.